PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Morressier joins the fight for science with federated integrity suite for authors and publishers

2023-05-24
(Press-News.org) Berlin and Washington DC, May 24, 2023 – Morressier announced today an integrity suite that will be offered as part of its end-to-end platform, designed to increase the quality of and trust in the outputs of scientific research.

Pre-flight checks for authors will flag potential quality issues, check for completeness of submissions, and provide recommendations for improvements in areas such as language.

Publishers using the Morressier platform now have access to a powerful suite of automated tools to help them identify integrity issues early and at scale. Plagiarism detection tools in the Morressier platform, for instance, indicate phrases in submissions that may be similar, identical to, or paraphrased from other work, while showing the potential source work in context. Reports are accessible in a powerful but easy-to-use integrity dashboard.

The Morressier publisher integrity suite uses proprietary Morressier technologies as well as federated access to a growing market of third-party solutions. It currently includes: detection of retracted content, plagiarism, citation manipulation, AI-generated text, and tortured phrases, as well as confirmation of author and co-author identities with a multi-step automatic verification process using Ringgold, ORCiD and other industry standards. A raft of other checks are under development, including paper-mill detection, salami slicing, and image manipulation. Morressier will be investing heavily to be the first to market with all major solutions to support integrity and quality.

Sami Benchekroun, Morressier co-founder and CEO: “Publishers are facing an integrity crisis due to the rapidly expanding scale of published output, the phenomenal growth in the capabilities of generative AI, and systemic issues that have led to a substantial rise in fraud. We all need to urgently pull together to resolve this. I’m not being dramatic in saying that the future of scientific consensus relies on us winning this fight.”

Jennifer Goodrich, Morressier Vice President of Product: “We are combining Morressier’s proprietary technology and data with a variety of third-party solutions to address a range of integrity issues from image manipulation to paper-mill detection. The benefit to publishers is that we do the heavy lifting of evaluating these evolving solutions and integrating them right where they are needed: in workflows across the publishing lifecycle.”

Othman Altalib, Morressier Chief Growth Officer: “If publishers are going to rise to the integrity challenge, they will need the support of a broad field of innovators. As a tech company that has come into the publishing game, Morressier is bridging the gap between publishers and a rapidly growing set of integrity solution providers. By working together, we aim to make a significant impact in this fight for trust in science.”

–ENDS

About Morressier

Morressier provides societies and publishers with workflows for transforming scholarly communications. Driven by the belief that technology will transform every step of the entire publishing journey starting from the very first scientific ideas, it is headquartered in Berlin and has offices in London and Washington DC. Visit morressier.com and follow us@Morressier.

END


ELSE PRESS RELEASES FROM THIS DATE:

SEngine Precision Medicine demonstrates potential of PARIS® Test to find unexpected therapeutic options for treating cancer

2023-05-24
SEngine Precision Medicine, the precision oncology innovator matching patients to medicines based on their own tumor samples, announces the publication of a new case report showing a patient’s remarkable response to an off-label therapy identified by its PARIS® Test. Despite standard-of-care chemotherapy and two surgeries, the patient’s low-grade serous ovarian cancer (LGSOC) was progressing and her prognosis was terminal. But by testing a range of therapies in organoids grown from the patient’s own tumor sample, SEngine’s PARIS® Test identified as ...

Logging on for health: More older adults use patient portals, but access and attitudes vary widely

2023-05-24
Far more older adults these days log on to secure websites or apps to connect with their health information or have a virtual health care appointment, compared with five years ago, a new poll shows. Overall, 78% of people aged 50 to 80 have used at least one patient portal, up from 51% in a poll taken five years ago, according to findings from the University of Michigan National Poll on Healthy Aging. Of those with portal access, 55% had used it in the past month, and 49% have accounts on more than one portal. But the poll also reveals major disparities, with some groups of older adults less likely to use patient portals, or more likely ...

Life stressors may contribute to multiple sclerosis flares, disability

2023-05-24
A Michigan Medicine-led study finds that stressors across the lifespan — including poverty, abuse and divorce — are associated with worsening health and functional outcomes for people with multiple sclerosis. Using survey data from more than 700 people with MS, researchers discovered that stressful events occurring both in childhood and adulthood contributed significantly to participants’ level of disability. The results are published in Brain and Behavior. “MS is the leading cause of non-traumatic ...

Existing drugs point to first treatment for strokes linked to dementia

2023-05-24
People who experience a type of stroke linked with nearly half of all dementias could be treated for the first time by repurposing two cheap and common drugs, a trial shows.   Researchers found that isosorbide mononitrate and cilostazol, which are already used to treat other heart and circulatory diseases, can safely improve the debilitating outcomes people experience after lacunar stroke.   The two drugs, which were found to be even more effective when used in combination, could be available as a treatment for lacunar strokes within five years, if the results are ...

Long or short menstrual cycles linked to higher risk of CVD including atrial fibrillation

2023-05-24
Research Highlights: An analysis of data for more than 58,000 women in the U.K. Biobank found that both short (less than 21 days) or long (more than 35 days) menstrual cycles were associated with the development of cardiovascular disease, heart attack or atrial fibrillation (AFib). Short or long menstrual cycle length was associated with a 19% higher risk of heart disease among those women compared to women with menstrual cycle length between 22 to 34 days. Irregular menstrual cycle length was associated with a 40% higher risk of atrial ...

Physical activities like a daily, 20-minute walk may help reduce disparities in heart health

2023-05-24
Statement Highlights: Addressing low levels of physical activity among people in some targeted groups has the potential to improve equity in cardiovascular health. Physical activity levels are lower among some population groups known to have higher cardiovascular disease risk, including adults who are older, female, Black, have depression, have disabilities, have lower socioeconomic status or live in rural areas. It’s important to improve resources and opportunities to decrease barriers to physical activity. Physical activity initiatives should engage the community and ...

Cleft lip caused by combination of genes and environment

2023-05-24
A cleft lip or palate arises from the combined effects of genes and inflammatory risk factors experienced during pregnancy, such as smoking or infections, finds a new study led by UCL researchers. The study, published in Nature Communications, has revealed for the first time how genetic and environmental factors come together to form a cleft lip or palate in a developing foetus. Cleft lip, with or without cleft palate, is the most common craniofacial malformation seen at birth, affecting one in 700 live births. It can have devastating ...

Study finds association between long-term exposure to air pollution and severe COVID-19

2023-05-24
A long history of exposure to air pollution is associated with a higher risk of developing severe disease, admission to hospital or an intensive care unit (ICU) and death by COVID‑19 according to a study led by the Barcelona Institute for Global Health (ISGlobal), a research centre supported by the ”la Caixa” Foundation. The study, published in the journal Nature Communications, was based on a large cohort of 4,660,502 adults resident in Catalonia in 2020, the year the Spanish autonomous community had a high incidence of COVID-19. The ...

Major progress in curing brain tumours

Major progress in curing brain tumours
2023-05-24
Researchers at the University of Gothenburg, working with French colleagues, have successfully developed a method able to kill the aggressive brain tumour glioblastoma. By blocking certain functions in the cell with a docked molecule, the researchers cause the cancer to die of stress. Cancer cells, especially those that form aggressive tumours, are in one way or another out of control and live a very stressful existence. To manage this stress, the cancer cells hijack mechanisms that the healthy cells use to regulate protein production and process the surplus proteins that they create. Without these hijacked mechanisms, ...

Computer‐aided diagnosis improves breast ultrasound expertise in multicenter study

Computer‐aided diagnosis improves breast ultrasound expertise in multicenter study
2023-05-24
Leesburg, VA, May 17, 2023—According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), deep learning–based computer-aided diagnosis (CAD) for breast lesion classification on ultrasound significantly improved radiologists’ diagnostic performance—particularly for reducing the frequency of benign breast biopsies. Compared with the literature supporting CAD at tertiary and/or urban centers, results from this prospective multicenter study of radiologists without ...

LAST 30 PRESS RELEASES:

Federal Trade Commission actions on prescription drugs, 2000-2022

Fluoride exposure during pregnancy linked to increased risk of childhood neurobehavioral problems, study finds

The Ukraine war caused migrating eagles to deviate from their usual flight plan

Endangered migrating eagles impacted by Ukraine war

Study explores association between fluoride exposure in pregnancy and neurobehavioral issues in young children

Using magnetic resonance spectroscopy to design safer, higher-performance lithium batteries

Should your exercise goals be in minutes or steps? Study suggests they are equally beneficial

Racial and ethnic inequities in cancer care continuity during the COVID-19 pandemic among those with SARS-CoV-2

Effect of sleep restriction on adolescent cognition by adiposity

Webb Telescope offers first glimpse of an exoplanet’s interior

Alkyl-aromatic hybrid micelles formed from emergent umbrella-shaped molecules

First study from the African Ancestry Neuroscience Research Initiative identifies key genes in the brain that account for higher rates of some brain disorders in Black Americans

NIH awards Coast-to-Coast Consortium $5.6 million for All of Us Research Program

Ben-Gurion University scientist hunts for drug candidate to treat brain tumors

New Health Blueprint maps healthier future for rural, underserved Southwest Virginia

Survival benefit associated with participation in clinical trials of anticancer drugs

Expanding on the fundamental principles of liquid movement

Chemical Insights Research Institute partners with Duke University and the East-West Center to examine dust and ash from devastating Hawai’ian wildfires

NCCN publishes new resource for patients with intestinal cancer type most have never heard of before diagnosis

Subduction zone splay faults compound hazards of great earthquakes

Record low Antarctic sea ice ‘extremely unlikely’ without climate change

After hundreds of years, study confirms Bermuda now home to cownose rays

Scientists uncover promising treatment target for resistant brain cancer

Revolutionizing cancer treatment by intracellular protein delivery using hybrid nanotubes

Chemist Julian West makes C&EN magazine’s ‘Talented 12’ list

Robot-phobia could exasperate hotel, restaurant labor shortage

Study offers new detail on how COVID-19 affects the lungs

Body’s ‘message in a bottle’ delivers targeted cancer treatment

1 in 4 parents say their teen consumes caffeine daily or nearly every day

What makes some brown algae shimmer and others not?

[Press-News.org] Morressier joins the fight for science with federated integrity suite for authors and publishers